Table 1.
Baseline Clinical Characteristics of the Study Population
| Characteristic | Total Population | Atrial Fibrillation (N=35) | No Atrial Fibrillation (N=35) | P-value for difference |
|---|---|---|---|---|
| Age, yrs, mean (SD) | 68.13 (8.98) | 68.03 (8.64) | 68.23 (9.43) | 0.92 |
| Male, n (%) | 46/70 (0.65) | 23/35 (0.65) | 23/35 (0.65) | 1.00 |
| History of cardiovascular disease, n (%) | 21/69 (0.30) | 12/35 (0.34) | 9/34 (0.26) | 0.65 |
| Active Cancer, n (%) | 46/70 (0.66) | 23/35 (0.66) | 23/35 (0.66) | 1.00 |
| History of hypertension, n (%) | 54/69 (0.78) | 29/35 (0.83) | 25/34 (0.74) | 0.51 |
| History of Diabetes, n (%) | 22/69 (0.32) | 13/35 (0.37) | 9/34 (0.26) | 0.49 |
| Current or prior smoker, n (%) | 21/69 (0.30) | 12/35 (0.34) | 9/34 (0.26) | 0.65 |
| Statin Use, n (%) | 29/69 (0.42) | 14/35 (0.40) | 15/34 (0.44) | 0.91 |
| Systolic Blood pressure, mmHg, mean (SD) | 129.00 (17.92) | 127.84 (18.03) | 129.96 (18.17) | 0.70 |
| Low density lipoprotein, mg/dL, mean (SD) | 90.74 (34.13) | 94.55 (37.27) | 86.37 (30.24) | 0.36 |
| High density lipoprotein, mg/dL, mean (SD) | 47.69 (22.71) | 44.39 (13.51) | 51.10 (29.23) | 0.25 |
| Body mass index, kg/m2 mean (SD) | 27.87 (6.33) | 28.57 (6.77) | 27.18 (5.86) | 0.36 |
| Framingham Risk Score, mean (SD) | 8.50 (5.89) | 8.75 (5.87) | 8.28 (6.07) | 0.81 |
SD = Standard deviation